Angelman syndrome (AS) is a rare neurogenetic disorder that affects approximately one in 15,000 people – about 500,000 individuals worldwide. Symptoms include, but are not limited to: delayed developmental milestones; gross and fine motor impairment; difficulty with feeding and swallowing; issues; loss of functional speech and epilepsy.
FAST has a vision of a world where lives are no longer limited by a diagnosis of Angelman syndrome.
The mission of the Foundation for Angelman Syndrome Therapeutics Australia is to improve the quality of life for individuals with Angelman syndrome through timely diagnosis, access to best practices in care and treatments, and advancing research for a cure.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Cairns, Queensland, Au
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://cureangelman.org.au/
- Keywords
- Cairns.
- HQ
- Cairns, Queensland
- Competitors
- Angelman Syndrome Foundation, AS2 Bio Inc, Cure GM1 Foundation, Foundation for Angelman Syndrome Therapeutics, Ligantic, FAST Latam (Foundation for Angelman Syndrome Therapeutics Latin America), Northern Health, Foundation for Angelman Syndrome Therapeutics UK (FAST UK), Colin Farrell Foundation, National Organization for Rare Disorders.
Fast Australia - Foundation For Angelman Syndrome Therapeutics Questions
Fast Australia - Foundation For Angelman Syndrome Therapeutics's website is https://cureangelman.org.au/
Fast Australia - Foundation For Angelman Syndrome Therapeutics's LinkedIn profile is https://au.linkedin.com/company/fastaustralia
Fast Australia - Foundation For Angelman Syndrome Therapeutics has
6 employees.
View email and phone details for 6
employees at Fast Australia - Foundation For Angelman Syndrome Therapeutics.
Fast Australia - Foundation For Angelman Syndrome Therapeutics's industry is
Research Services
Fast Australia - Foundation For Angelman Syndrome Therapeutics's top competitors are
Angelman Syndrome Foundation,
As2 Bio Inc,
Cure Gm1 Foundation,
Foundation For Angelman Syndrome Therapeutics,
Ligantic,
Fast Latam (Foundation For Angelman Syndrome Therapeutics Latin America),
Northern Health,
Foundation For Angelman Syndrome Therapeutics Uk (Fast Uk),
Colin Farrell Foundation,
National Organization For Rare Disorders.
Fast Australia - Foundation For Angelman Syndrome Therapeutics's categories are Research Services
Fast Australia - Foundation For Angelman Syndrome Therapeutics's founding year is 2009
